Medical device risk (re)classification: lessons from the FDA’s 515 Program Initiative

Abstract

#### Key messages box The 1976 Medical Device Amendments to the Food, Drug and Cosmetic Act granted the US Food and Drug Administration (FDA) regulatory authority over medical devices. Congress intended for FDA’s review requirements to correspond to the amount of information needed to provide ‘